vol1 - Page 235
Page 235
Previous ,
Next ,
Original Image
Return to Index
(more than one year) to control their elevated intraocular
pressures. In one instanter Me_itt closely followed a glaucoma
patient (Robert Randall) over a period of fourteen months. _AT/
Merrittss evaluations from the period (1976-78) included close
monitoring of this patient's IOP responses to cannabis therapy and
included an analysis of the effects of 'these lOP reductions on
this patient's retention of visual field_ 5_I_/ Through his
continuing study, Dr_ Merritt followed several other glaucoma
patients who employed marijuana under his supervision for even
longer periods of time. Lackinq licit access to marijuana,
however, many of these patients were forced to fend for
themselves at some point in Merrittes evaluations. 5_9-/
b. Marijuanaes Safety for Use Under Medical
Supervision in the Treatment of Glaucoma
There is a vast body.of literature on marijuana_s
physical and psychological effects. _-_-q/ There is also highly
specific and very extensive scientific information on marijuana_s
safety for medical use in numerous therapeutic settings_ 521/
517/ Affidavit of Dr. John Merritt, _ 14-15.
51_/ _. at _ 27-31.
5_2_Q/ ACT Official State Reports, Volume Xl, New Jersey Glaucoma
Protocol at 39, (Ma_uana: ...... An Annotate_. Biblio_raDhv, Waller_
..L Coy W., etal., New York, 1976. This reference work, produced by
the Research Institute of Pharmaceutical Sciences (RIPS) at the
University of Mississippi, contains 3045 abstracted entries of
scientific and medical journal articles on cannabis which were
published from 1964 through 1975o)
521/ _. at 40.
Previous ,
Next ,
Return to Index